🇺🇸 FDA
Patent

US 7629168

Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof

granted A61KA61K35/12A61P

Quick answer

US patent 7629168 (Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof) held by Kuraray Medical Inc. expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kuraray Medical Inc.
Grant date
Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K35/12, A61P, A61P3/10